Betamethasone
- Atc Codes:A07EA04#C05AA05#D07AC01#D07XC01#H02AB01#R01AD06#R03BA04#S01BA06#S01CB04#S02BA07#S03BA03
- CAS Codes:378-44-9#5593-20-4#151-73-5#360-63-4#2152-44-5
- PHARMGKB ID:378-44-9#5593-20-4#151-73-5#360-63-4#2152-44-5
Table of contents
- Brand Names
- Drug Combinations
- Chemistry
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Unlabeled Use
- Pregnancy and Lactation Implications
- Contraindications
- Warnings and Precautions
- Adverse Reactions
- Toxicological Effects
- Genes that may be involved
- Substrate of
- Inhibits
- Induces
- Drug Interactions
- Nutrition/Nutraceutical Interactions
- Dosage
- Pharmacokinetics and Pharmacodynamics
- Special Considerations
Brand Names
Europe
Austria: Betnovate, Celestan Biphase, Diproderm; Belgium: Celestone, Diprophos; Bulgaria: Dermocort, Betnovate; Cyprus: Betnovate, Celestone, Medobeta, Osmoran; Czech Republic: Beloderm, Belosalic, Betesil, Betnovate, Diprophos, Diprosalic, Diprosone, Kuterid; Denmark: Betnovat, Bettamousse, Celeston, Diproderm, Diprolen, Diprospan; Estonia: Betnovate, Celestoderm-V; Finland: Bemetson, Betapred, Betnovat, Bettamousse, Celestoderm, Diproderm, Diprolen; France: Bétaméthasone, Betesil, Betnesol, Betneval, Buccobet, Celestene, Celestoderm Relais, Diprolene, Diprosone, Diprostene; Germany: Bemon, Beta, Betacreme, Betadoc Creme, Betagalen Creme, BetaLotio, Betasalbe, Betnesol V, Betnovate V crinale, Celestan V, Cordes Beta, Deflatop 0.1% Schaum, Diprosis, Diprosone, Linolacort Bet, Soderm Creme; Greece: Alo-Haar, Bagoco, Betamatic, Betatape, Betnesol, Betnovate, Bettamousse, Celestene, Celestone, Flogozyme, Helpoderm, Iracliton, Locason Scalp, Movithiol, Orecortex, Osmoran, Propiochrone, Propioform, Rubijervin, Sanorvil, Takinol-N, Tenderm, Welmin, Youderm; Hungary: Betesil, Diprophos, Fucicort; Ireland: Betacap Scalp, Betnelan, Betnesol, Betnovate, Bettamousse, Diprosone; Italy: Bentelan, Betametasone, Bettamousse, Celestone, Ecoval; Luxembourg: Betnesol, Celestone; Netherlands: Betamethason, Betnelan Crème, Betnesol Lavement, Celestone, Diprolene, Diprosone; Poland: Beloderm, Betnesol, Betnovate, Celestone, Diprolene, Diprosone, Flosteron Solubile; Portugal: Betnovate, Celesdepot, Celestone, Cilestoderme, Diprofos Depot, Diprosone, Soluderme; Romania: Beloderm Crema, Betaderm, Betametazona, Diprophos, Ekarzin, Fucicort, Ophtamesone; Slovakia: Beloderm, Belogent, Belosalic, Betesil, Diprophos, Diprosalic, Diprosone, Kuterid; Slovenia: Celestone; Spain: Betnovate, Bettamousse, Celestoderm, Celestone Cronodose, Diproderm; Sweden: Betapred, Betnoderm, Betnovat, Bettamousse, Celeston Bifas, Diproderm, Diprolen; UK: Betacap Scalp Application, Betnelan, Betnesol Eye Ointment, Betnovate, Bettamousse, Diprosalic Ointment, Diprosone Cream.
North America
Canada: Betaderm, Betaject, Betnesol, Betnovate, Celestone Soluspan, Diprolene, Diprosone, Ectosone, Prevex B, Taro-Sone, Topilene, Topisone, Valisone Scalp Lotion; USA: Beta-Val, Celestone, Diprolene, Luxiq.
Latin America
Argentina: Bactisona, Betametasona, Betatopic, Betnovate, Blacor, Cevicort Crema, Coid Crema, Deltalaf, Dermizol, Dicasone 0.6, Diprosone, Lazar-Cort, Quiacort, Transderma B, Vitacortil B; Brazil: Beclonato, Benevat, Beta Long, Betaderm, Betametagen, Betametasona, Betaprospan, Betaspan, Betatrinta, Betnelan, Betnolon, Betnovate, Betrat B, Betrospan, Betsona, Celestone, Diprobeta, Diprocort, Diprosen, Diprosone, Diprospan, Duoflam, Kóide, Sensitex, Valbet; Mexico: Betametasona, Betnovate, Celestone, Cronolevel, Dermoval-Tocogino, Diprofast, Diprospan, Dison’s Dex, Erispan, Reubaxona.
Asia
Japan: Antebate, Asdeloson, Berbesolone, Betametha, Betamethasone, Betnevate, Rinderon, Rinesteron, Steralol-B.
Drug combinations
Betamethasone and Calcipotriene
Betamethasone and Clotrimazole
Betamethasone and Desloratadine
Betamethasone and Gentamicin
Betamethasone and Dexchlorpheniramine
Betamethasone and Hyaluronidase
Betamethasone and Loratadine
Betamethasone and Salicylic Acid
Betamethasone and Sodium Phosphate
Betamethasone, Clioquinol, and Gentamicin
Betamethasone, Clotrimazole, and Gentamicin
Betamethasone, Gentamicin, and Metamizol
Betamethasone, Gentamicin, Nystatin, and Tolnaftate
Other Betamethasone combinations: Cyanocobalamin (Vitamin B~12~); Hydroxocobalamin (Vitamin B~12a~)
Chemistry
Betamethasone: C~22~H~29~FO~5~. Mw: 392.46. (1) Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11β,16β)-; (2) 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione. CAS-378-44-9 (1962).
Betamethasone Dipropionate: C~28~H~37~FO~7~. 504.59. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11β,16β). CAS-5593-20-4 (1974).
Betamethasone Sodium Phosphate: C~22~H~28~FNa~2~O~8~P. Mw: 516.40. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11b,16b)-. CAS-151-73-5; CAS-360-63-4 (betamethasone dihydrogen phosphate).
Betamethasone Valerate: C~27~H~37~FO~6~. Mw: 476.58. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-, (11β,16β)-. CAS-2152-44-5 (1969).
Pharmacologic Category
Hormones and Synthetic Substitutes; Adrenals; Corticosteroids. Skin and Mucous Membrane Agents; Anti-inflammatory Agents. (ATC-Code: A07EA04; C05AA05; D07AC01; D07XC01; H02AB01; R01AD06; R03BA04; S01BA06; S01CB04; S02BA07; S03BA03).
Mechanism of action
Controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes and fibroblasts, reverses capillary permeability, and causes lysosomal stabilization at the cellular level to prevent or control inflammation.
Therapeutic use
Anti-inflammatory and immunosuppressant agent (due to its glucocorticoid effects). Inflammatory dermatoses such as seborrheic or atopic dermatitis, neurodermatitis, anogenital pruritus, psoriasis, inflammatory phase of xerosis.
Pregnancy and lactiation implications
Due to its positive effect on stimulating fetal lung maturation, the injection is often used in premature labor (24-34 weeks gestation). Topical products are not recommended for extensive use, in large quantities, or for long periods of time in pregnant women. Use with caution while breast-feeding (do not apply to nipples).
Unlabeled use
Accelerating fetal lung maturation in preterm labor.
Contraindications
Hypersensitivity to betamethasone, other corticosteroids, or any component of the formulation. Systemic fungal infections. Intramuscular administration contraindicated in idiopathic thrombocytopenia purpura.
Warnings and precautions
May cause hypercorticism or suppression of hypothalamic-pituitary-adrenal axis, which may lead to adrenal crisis. Use caution upon withdrawal and discontinuation of the drug and transference from systemic corticosteroids to inhaled products. May increase the incidence of secondary infection, mask acute infection (including fungal infections), prolong or exacerbate viral infections, or limit response to vaccines. Exposure to chickenpox should be avoided. Not for treatment of ocular herpes simplex, cerebral malaria or viral hepatitis. Restrict use in active tuberculosis (only in conjunction with antituberculosis treatment). Possible development of Kaposi’s sarcoma (with long treatment). Acute myopathy reported with high doses. May cause psychiatric disturbances (depression, euphoria, insomnia, mood swings, and personality changes). Discontinuation and/or dose reductions should be gradual. Caution in heart failure (risk of fluid retention and hypertension with prolonged use), diabetes mellitus (may produce hyperglycemia), gastrointestinal disease (perforation risk), hepatic or renal impairment (fluid retention), myasthenia gravis (exacerbation of symptoms, especially during initial treatment), following acute myocardial infarction (risk of myocardial rupture), osteoporosis (risk of increased bone loss and osteoporotic fractures), history of seizure disorder (seizures with adrenal crisis reported), cataracts and/or glaucoma. Metabolic clearance of corticosteroids increases in hyperthyroidism and decreases in hypothyroidism. May affect growth velocity in pediatric patients. Should be used cautiously in the elderly. Occlusive dressings should not be used on weeping or exudative lesions. Should not be used for treatment of rosacea, perioral dermatitis, on face, groin, axillae, or in a diapered area (high potency topical product). Avoid concurrent use of other corticosteroids.